Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - Brain, 2019 - academic.oup.com
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …

Neuroinflammation in Alzheimer's disease

MT Heneka, MJ Carson, J El Khoury… - The Lancet …, 2015 - thelancet.com
Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the
neuronal compartment, but includes strong interactions with immunological mechanisms in …

Immune attack: the role of inflammation in Alzheimer disease

FL Heppner, RM Ransohoff, B Becher - Nature Reviews Neuroscience, 2015 - nature.com
The past two decades of research into the pathogenesis of Alzheimer disease (AD) have
been driven largely by the amyloid hypothesis; the neuroinflammation that is associated with …

Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models

SJ Webster, AD Bachstetter, PT Nelson… - Frontiers in …, 2014 - frontiersin.org
The goal of this review is to discuss how behavioral tests in mice relate to the pathological
and neuropsychological features seen in human Alzheimer's disease (AD), and present a …

The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease

BJ Matchett, LT Grinberg, P Theofilas, ME Murray - Acta neuropathologica, 2021 - Springer
Alzheimer's disease (AD) is neuropathologically characterized by the intracellular
accumulation of hyperphosphorylated tau and the extracellular deposition of amyloid-β …

Long road to ruin: noradrenergic dysfunction in neurodegenerative disease

D Weinshenker - Trends in neurosciences, 2018 - cell.com
It has been known for decades that degeneration of the locus coeruleus (LC), the major
noradrenergic nucleus in the brain, occurs in both Alzheimer's disease (AD) and Parkinson's …

Targeting neuroinflammation to treat Alzheimer's disease

A Ardura-Fabregat, E Boddeke, A Boza-Serrano… - CNS drugs, 2017 - Springer
Over the past few decades, research on Alzheimer's disease (AD) has focused on
pathomechanisms linked to two of the major pathological hallmarks of extracellular …

Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology

F Kosel, JMS Pelley, TB Franklin - Neuroscience & Biobehavioral Reviews, 2020 - Elsevier
Transgenic mouse models have been used extensively to model the cognitive impairments
arising from Alzheimer's disease (AD)-related pathology. However, less is known about the …

Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine

MT Heneka, F Nadrigny, T Regen… - Proceedings of the …, 2010 - National Acad Sciences
Locus ceruleus (LC)-supplied norepinephrine (NE) suppresses neuroinflammation in the
brain. To elucidate the effect of LC degeneration and subsequent NE deficiency on …

Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease

JM Rorabaugh, T Chalermpalanupap, CA Botz-Zapp… - Brain, 2017 - academic.oup.com
Abstract See Grinberg and Heinsen (doi: 10.1093/brain/awx261) for a scientific commentary
on this article. Clinical evidence suggests that aberrant tau accumulation in the locus …